|
| << previous | next >> |
Journal description
All volumes of the corresponding journal
All issues of the corresponding volume
All articles of the corresponding issues
Details for article 21 of 257 found articles
| Title: |
163O Patient-reported outcomes (PROs) from DESTINY-Breast03, a randomized phase III study of trastuzumab deruxtecan (T-DXd) vs trastuzumab emtansine (T-DM1) in patients (pts) with HER2-positive (HER2+) metastatic breast cancer (MBC) |
| Author: |
Curigliano, G. Dunton, K. Rosenlund, M. Janek, M. Cathcart, J. Liu, Y. Fasching, P.A. Iwata, H. |
| Appeared in: |
Annals of oncology |
| Paging: | Volume 33 () nr. S3 pages S196-S197 |
| Year: |
2022 |
| Contents: | |
| Publisher: |
European Society for Medical Oncology |
| Source file: |
Elektronische Wetenschappelijke Tijdschriften |
Details for article 21 of 257 found articles
| << previous | next >> |